StockClub
ASNDAscendis Pharma A/S$ --
Ascendis Pharma A/S

Ascendis Pharma A/S

ASND

$ -

-

You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.

analyticsIncome Statement Summary

FY2025 Full YearUpdated: 12/31/2025

Revenue

attach_money
692M EUR
YoY +90.2%

Operating Income

bar_chart
-131M EUR
YoY +53.0%

Net Income

verified
-219M EUR
YoY +42.1%

EPS

pie_chart
-3.62EUR
YoY +44.6%

Quarterly Performance

Quarterly revenue and net income trend

RevenueOperating IncomeNet Income
No quarterly data available

Full-Year Progress

FY2025
Net Income Progress117.3%On Track
Revenue Progress717.8M
Revenue Forecast708.3M
Net Income Progress-227.7M
Net Income Forecast-194.1M

Income Statement Details

Item
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Revenue
Cost of revenue
Gross profit
692
103
589
Research & development
Selling & marketing
Selling, general and administrative
Other operating expenses
Operating income
284
0
436
823
-131
Interest expense
Income before tax
Income tax expense
Net income
77
-204
15
-219

Unlock Long-Term Income Statement Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.